138 related articles for article (PubMed ID: 9988520)
1. Partial in vitro digestion of active gliadin-related peptides in celiac disease.
Cornell HJ
J Protein Chem; 1998 Nov; 17(8):739-44. PubMed ID: 9988520
[TBL] [Abstract][Full Text] [Related]
2. In vitro mucosal digestion of synthetic gliadin-derived peptides in celiac disease.
Cornell HJ; Rivett DE
J Protein Chem; 1995 Jul; 14(5):335-9. PubMed ID: 8590601
[TBL] [Abstract][Full Text] [Related]
3. Amino acid composition of gliadin fractions which may be toxic to individuals with coeliac disease.
Cornell HJ; Maxwell RJ
Clin Chim Acta; 1982 Aug; 123(3):311-9. PubMed ID: 6811164
[TBL] [Abstract][Full Text] [Related]
4. Mucosal digestion studies of whole gliadin fractions in coeliac disease.
Cornell HJ
Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():44-9. PubMed ID: 2310157
[TBL] [Abstract][Full Text] [Related]
5. Digestion of gliadin peptides by intestinal mucosa from control or coeliac children.
Carchon H; Serrus M; Eggermont E
Digestion; 1979; 19(1):1-5. PubMed ID: 378739
[TBL] [Abstract][Full Text] [Related]
6. Amino acid composition of peptides remaining after in vitro digestion of a gliadin sub-fraction with duodenal mucosa from patients with coeliac disease.
Cornell HJ
Clin Chim Acta; 1988 Sep; 176(3):279-89. PubMed ID: 3180479
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in coeliac-toxic gliadin peptides.
Cornell HJ; Wills-Johnson G
Amino Acids; 2001; 21(3):243-53. PubMed ID: 11764405
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease.
Matysiak-Budnik T; Candalh C; Dugave C; Namane A; Cellier C; Cerf-Bensussan N; Heyman M
Gastroenterology; 2003 Sep; 125(3):696-707. PubMed ID: 12949716
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the gliadin-derived peptides which are biologically active in coeliac disease.
Cornell H; Wieser H; Belitz HD
Clin Chim Acta; 1992 Dec; 213(1-3):37-50. PubMed ID: 1477986
[TBL] [Abstract][Full Text] [Related]
10. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
Skovbjerg H; Koch C; Anthonsen D; Sjöström H
Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
[TBL] [Abstract][Full Text] [Related]
11. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue.
Piper JL; Gray GM; Khosla C
Biochemistry; 2002 Jan; 41(1):386-93. PubMed ID: 11772038
[TBL] [Abstract][Full Text] [Related]
12. Further evidence of a primary mucosal defect in coeliac disease.
Cornell HJ; Rolles CJ
Gut; 1978 Apr; 19(4):253-9. PubMed ID: 648934
[TBL] [Abstract][Full Text] [Related]
13. Effects of gliadin peptides B1-B4 in celiac disease. I. Organ culture studies.
Stallmach A; Belitz HD; Gellermann B; Schäfer H; Wieser H; Stern M
J Pediatr Gastroenterol Nutr; 1987; 6(3):335-40. PubMed ID: 3430242
[TBL] [Abstract][Full Text] [Related]
14. Is it true that coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa.
Bernardo D; Garrote JA; Nadal I; León AJ; Calvo C; Fernández-Salazar L; Blanco-Quirós A; Sanz Y; Arranz E
Gut; 2009 Jun; 58(6):886-7. PubMed ID: 19433604
[No Abstract] [Full Text] [Related]
15. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue.
De Angelis M; Rizzello CG; Fasano A; Clemente MG; De Simone C; Silano M; De Vincenzi M; Losito I; Gobbetti M
Biochim Biophys Acta; 2006 Jan; 1762(1):80-93. PubMed ID: 16311022
[TBL] [Abstract][Full Text] [Related]
16. Targeting of gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR to Golgi complexes and vacuoles within celiac disease enterocytes.
Zimmer KP; Naim H; Weber P; Ellis HJ; Ciclitira PJ
FASEB J; 1998 Oct; 12(13):1349-57. PubMed ID: 9761778
[TBL] [Abstract][Full Text] [Related]
17. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides.
Lebreton C; Ménard S; Abed J; Moura IC; Coppo R; Dugave C; Monteiro RC; Fricot A; Traore MG; Griffin M; Cellier C; Malamut G; Cerf-Bensussan N; Heyman M
Gastroenterology; 2012 Sep; 143(3):698-707.e4. PubMed ID: 22750506
[TBL] [Abstract][Full Text] [Related]
18. Deficient activity of mammalian prolyl oligopeptidase on the immunoactive peptide digestion in coeliac disease.
Garcia-Horsman JA; Venäläinen JI; Lohi O; Auriola IS; Korponay-Szabo IR; Kaukinen K; Mäki M; Männistö PT
Scand J Gastroenterol; 2007 May; 42(5):562-71. PubMed ID: 17454876
[TBL] [Abstract][Full Text] [Related]
19. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells.
De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V
Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797
[TBL] [Abstract][Full Text] [Related]
20. Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa.
Cornell HJ; Auricchio RS; De Ritis G; De Vincenzi M; Maiuri L; Raia V; Silano V
Pediatr Res; 1988 Aug; 24(2):233-7. PubMed ID: 3186334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
